Breast Neoplasms: all 12,820 studies
Page 21 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Tele-nursing Practices Based on Technological Competence Theory in Breast Cancer PatientsRecruitingNCT05998655Not applicable
- Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and MastectomyNot yet recruitingNCT05993559Phase 3
- Awareness Scale Related To Physiotherapy After Breast Cancer: A Scale Development StudyRecruitingNCT05992441
- Increasing Access to Fertility Preservation for Women with Breast CancerRecruitingNCT05989776Not applicable
- Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant TherapyRecruitingNCT05989347Phase 1
- I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast CancersNot yet recruitingNCT05986071Phase 1/2
- Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast CancerRecruitingNCT05984888Not applicable
- The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer SurvivorsRecruitingNCT05983380Not applicable
- Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast CancerRecruitingNCT05983107Phase 2
- Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast CancerNot yet recruitingNCT05983094Phase 2
- Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast CancerRecruitingNCT05982626Not applicable
- Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast CancerRecruitingNCT05982093Phase 2
- Young Breast Cancer Survivors StudyRecruitingNCT05981716
- Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer PatientsRecruitingNCT05981326Not applicable
- Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast CancerRecruitingNCT05981014Phase 1/2
- Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast CancerRecruitingNCT05981001Phase 1/2
- A Real-world Study of Inetetamab for First-line Treatment of MBCNot yet recruitingNCT05980208
- Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line ChemotherapyNot yet recruitingNCT05979220Phase 2
- Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant ChemotherapyRecruitingNCT05978648Phase 2
- Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible ParticipantsRecruitingNCT05978128Not applicable
- BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast CancerRecruitingNCT05977036Not applicable
- Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer PatientsRecruitingNCT05976815Not applicable
- Regional Lymph Node Irradiation for High-risk pN0 Breast CancerRecruitingNCT05976412Not applicable
- Effectiveness of Personalized Surveillance and Aftercare for Breast CancerEnrolling by invitationNCT05975437
- Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast CancerRecruitingNCT05975190Not applicable
- Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer PatientsRecruitingNCT05974449Phase 2
- Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAvailableNCT05974410
- Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom MonitoringRecruitingNCT05974150
- COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical PatientsRecruitingNCT05972343
- Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer PatientsRecruitingNCT05968677Not applicable
- PD-1 +/- IL-4 Inhibition in ER+ Breast CancerNot yet recruitingNCT05967884Phase 2
- Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)RecruitingNCT05964504
- RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)RecruitingNCT05963464
- Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical TrialNot yet recruitingNCT05957939Phase 1
- Breast Cancer Exercise Intervention StudyRecruitingNCT05957068Not applicable
- Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast CancerRecruitingNCT05955170Phase 2
- Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) SubtypeRecruitingNCT05954442Phase 3
- T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low PatientsNot yet recruitingNCT05953168Phase 2
- Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary ChemotherapyRecruitingNCT05951699
- Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerRecruitingNCT05950945Phase 3
- Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast CancerRecruitingNCT05949983Not applicable
- Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast CancerRecruitingNCT05949541Phase 2
- OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older AdultsNot yet recruitingNCT05949424Phase 4
- Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After ChemotherapyRecruitingNCT05949333Phase 4
- DESTINY Breast Respond HER2-(Ultra)Low EuropeRecruitingNCT05945732
- A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCRecruitingNCT05945368Phase 2
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast CancerRecruitingNCT05941520Phase 2
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsRecruitingNCT05941507Phase 1/2
- Omission of ALND in Breast Cancer Patients With Axillary pCRRecruitingNCT05939830Not applicable
- Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 StudyRecruitingNCT05939310Not applicable
- Home_Based Digital Mindful Dance Program for Breast Cancer CasesRecruitingNCT05938686Not applicable
- SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuationRecruitingNCT05935384
- Omission of SLNB in CN0 Early Breast CancerRecruitingNCT05935150Not applicable
- Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast CancerRecruitingNCT05933733
- A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsRecruitingNCT05932862Phase 1
- Effects of Cryotherapy on Taxane-Induced Neuropathy in Patients With Breast CancerRecruitingNCT05928429Not applicable
- Study of TFX06 in Women With Advanced Breast Cancer.RecruitingNCT05927779Phase 1/2
- Reliability And Validity Study Of "The Evaluation Tool For Myofascial Adhesions In Patients After Breast Cancer" In Turkish LanguageNot yet recruitingNCT05923164
- Understanding CARdiac Events in Breast CancerRecruitingNCT05921279
- Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic ChemotherapyRecruitingNCT05921253Early Phase 1
- Realistic Evaluation of a Job Retention Program After Breast CancerRecruitingNCT05919498
- Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BCRecruitingNCT05918328Phase 2
- Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics PlatformRecruitingNCT05916755
- Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PETRecruitingNCT05914402Not applicable
- Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast CancerRecruitingNCT05912062
- A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast CancerRecruitingNCT05911958Phase 2
- Muscle Energy Technique and Mulligan's Mobilization in Breast Cancer Surgery PatientsRecruitingNCT05911867Not applicable
- Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast CancerRecruitingNCT05910710
- Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)RecruitingNCT05909332Phase 3
- Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)RecruitingNCT05907681
- COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast CancerRecruitingNCT05906407
- Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)RecruitingNCT05904964Phase 3
- Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral NeuropathyRecruitingNCT05904340Not applicable
- Magnetic Resonance Imaging in Radiotherapy for Breast CancerRecruitingNCT05902507
- DP303c in Patients With HER2-positive Advanced Breast CancerNot yet recruitingNCT05901935Phase 3
- Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer PatientsNot yet recruitingNCT05901025
- Estradiol Plus Olaparib for Breast Cancer (PHOEBE)RecruitingNCT05900895Phase 1
- Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast CancerRecruitingNCT05900206Phase 2
- Virtual Rehabilitation for Cancer SurvivorsRecruitingNCT05898789Not applicable
- Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast CancerRecruitingNCT05896865Not applicable
- A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerRecruitingNCT05894239Phase 3
- Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast CancerRecruitingNCT05893966
- New Model for Integrating Person-based Care (PbC) in the Treatment of Advanced HER2-negative Breast CancerRecruitingNCT05893368
- The Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast LessionsNot yet recruitingNCT05892380
- Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast CancerRecruitingNCT05891561Phase 2
- Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)RecruitingNCT05891093Phase 3
- A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line ChemotherapyRecruitingNCT05890287Not applicable
- A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast CancerNot yet recruitingNCT05889871Phase 3
- Non Surgical Treatment (Microwave Ablation) of Breast CancerNot yet recruitingNCT05887154Not applicable
- Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer SurvivorsRecruitingNCT05887102Not applicable
- Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI ResearchRecruitingNCT05885776Phase 2
- EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast CancerRecruitingNCT05883852Phase 3
- Evaluation of the Bexa™ Breast Examination (BBE)Not yet recruitingNCT05882019Not applicable
- Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast CancerRecruitingNCT05880927Phase 2
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25RecruitingNCT05879926Phase 3
- Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm PositionRecruitingNCT05878678Phase 2
- Creatine Supplementation and Resistance Training in Patients With Breast CancerRecruitingNCT05878106Not applicable
- Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With PembrolizumabRecruitingNCT05877859
- A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationRecruitingNCT05877599Phase 1
- Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast CancerNot yet recruitingNCT05876728